Adhesion molecules are transmembrane glycoproteins mediating cell-cell and cell extracellular matrix interactions. They control a number of fundamental biological processes including cell migration, differentiation, proliferation, and apoptosis. In the last decade there has been an increasing interest in the exploitation of these molecules as diagnostic and/or prognostic markers in tumor pathology. For example, a large number of studies have shown that loss of E-cadherin expression correlates with high tumor grade and advanced tumor stage in a number of malignancies. The analysis of adhesion molecule profile in a routine clinical setting needs further investigation in prospective multicenter studies.
5. Hynes RO, Lander AD. Contact and adhesive specificity in the association, migration, and targeting of cells and axons. Cell68:303-322, 1992
6.
6. Williams AF, Barclay AN. The immunoglobulin superfamily domain for cell surface recognition. Annu Rev Immunol6:381-405, 1988
7.
7. Rosen SD, Bertozzi CR. The selectins and their ligands. Curr Opin Cell Biol6:663-673, 1994
8.
8. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with the cellular matrix. Adv Immunol54:271-335, 1993
9.
9. Pignatelli M, Liu D, Nasim MM, Stamp GWH, Hirano S, Takeichi M.Morphoregulatory activities of Ecadherin and beta-1 integrin in colorectal tumor cell lines. Br J Cancer66:629-634, 1992
10.
10. Nigam AK, Savage FJ, Boulos PS, Stamp GWH, Liu D, Pignatelli M.Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer68:507-514, 1993
11.
11. Pignatelli M, Bodmer WF. Integrin cell adhesion molecules in colorectal cancer. J Pathol162:95-97, 1990
12.
12. Albelda SM, Mette SA, Elder DE. Integrin distribution in malignant melanoma: Association of the P3 subunit with tumor progression. Cancer Res50:6757-6764, 1990
13.
13. Pignatelli M, Vessey CJ. Adhesion molecules: Novel molecular tools in tumor pathology. Hum Pathol25:849-856, 1994
14.
14. Pignatelli M, Stamp GWH. Integrins in tumor development and spread. In: Tumor cell adhesion. I Hart, N Hogg (eds). Cancer Surveys New York: Cold Spring Harbor Laboratory Press, 1995, pp 113-127
15.
15. Akiyama SK, Larjava H, Yamada KM. Differences in the biosynthesis and differentiation of the fibronectin receptor in normal and transformed cultured human cells. Cancer Res50:1601-1607, 1990
16.
16. Pignatelli M, Smith MEF, Bodmer WF. Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas. Br J Cancer61:636-638, 1990
17.
17. Pignatelli M, Hanby AM, Stamp GWH. Low expression of 1P, a2, and x3 subunits of VLA integrins in malignant mammary tumors. J Pathol165:25-32, 1991
18.
18. Falconi R, Sacchi A, Reseau J, Kennel SJ. Monoclonal antibody to human carcinoma-associated protein complex: Quantitation in normal and tumor tissue. Cancer Res48:816-821, 1988
19.
19. Kennel SJ, Foote LJ, Falconi R, Sonnenberg A, Crouse C, Helmer ME. Analysis of the tumor-associated antigen TSP-180: Identity with a6j4 in the integrin superfamily. J Biol Chem264:15515-15521, 1989
20.
20. Agrez MV, Bates RC. Colorectal cancer and the integrin family of cell adhesion receptors: Current status and future directions. Eur J Cancer30A:2166-2170, 1994
21.
21. Basora N, Desloges N, Chang Q, Bouatrouss Y, Gosselin J, Poisson J, Sheppard D, Beaulieu J-F. Expression of the cx91l integrin in human colonic epithelial cells: Resurgence of the foetal phenotype in a subset of colonic cancers and adenocarcinoma cell lines. Int J Cancer75:738-743, 1998
22.
22. Bagutti C, Speight PM, Watt FM. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinoma of the oral cavity. J Pathol186:8-16, 1998
23.
23. Paulus W, Baur I, Schuppan D, Roggendoff W.Characterization of integrin receptor in normal and neoplastic brain. Am J Pathol143:154-163, 1993
24.
24. Sleeg P, Bevilacqua G, Sobel M, Liotta L.Invasion and metastasis. In: Cossman J (ed): Molecular genetics in cancer diagnosis. Elsevier, New York, pp. 49-53.
25.
25. Giancotti FG, Ruoslahti E.Elevated levels of the ox5PI fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell60:849-859, 1990
26.
26. Varner JA, Cheresh DA. Integrins and cancer. Curr Opin Cell Biol8:742-730, 1996
27.
27. Chan BM. In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science251:1600-1602, 1991
28.
28. Korman NJ, Hrabovsky SL. Basal cell carcinoma display extensive abnormalities in the hemidesmosome anchoring fibril complex. Exp Dematol2:139-144, 1993
29.
29. Liebert M, Washington R, Wedemeyer G, et al. Loss of co-localization of cx6P4 integrin VII in bladder cancer. Am J Pathol144:787-795, 1994
30.
30. Liu D, Gagliardi G, Nasim MM, et al. Transforming growth factor alpha can act as morphogen and/or mitogen in colorectal carcinoma cell line. Int J Cancer56:603-608, 1994
31.
31. Yap AS, Niessen CM, Gumbiner BM. The juxtamembrane region of the cadherin cytoplasmic tail support lateral clustering, adhesive strengthening, and interaction with p120ctn. J Cell Biol141:779-789, 1998
32.
32. Mole JP, Watt FM. The epidermal stem cell compartment: Variation in expression levels of E-cadherin and catenin within the basal layer of human epidermis. J Histochem Cytochem45:867-874, 1997
33.
33. Overduin M, Harvey TS, Bagby S, Tong KI, Yau P, Takeichi M, Ikura M.Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science267:386-389, 1995
34.
34. Hatta K, Takeichi M.Expression of N-cadherin adhesion molecules associated with early morphogenic events in chick development. Nature320:447-449, 1987
35.
35. Walsh FS, Barton CH, Putt W, Moore SE, Kelsell D, Spurr DN, Goodfellow PN. N-cadherin gene maps to human chromosome 18 and is not linked to the E-cadherin gene. J Neurochem55:805-812, 1990
36.
36. Soler AP, Harner GD, Knudsen KA, McBrearty FX, Grujic E, Salazar H, Han AC, Keshgegian AA. Expression of P-cadherin identifies prostate-specificantigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Am J Pathol151:471-478, 1997
37.
37. Hedrick L, Cho KR, Volgelstein B. Cell adhesion molecules as tumor suppressors. Trends Cell Biol3:36-39, 1995
38.
38. Bracke ME, VanRoy FM, Mareel MM. The E-cadherin/catenin complex in invasion and metastasis. In Gunthert U, Birchmeier W (eds): Attempt to understand metastasis formation I, metastasis-related molecules. Springer-Verlag, Berlin, pp. 123-163, 1996
39.
39. Soler AP, Knudsen KA, Tecson-Miguel A, McBrearty FX, Han AC, Salazar H.The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Hum Pathol26:1363-1369, 1995
40.
40. Peralta-Soler A, Knudsen KA, Jaurand M, et al. The differential expression of N-cadherin and E-cadherin distinguishes plueral mesothelioma from lung adenocarcinoma. Hum Pathol26:1363-1369, 1995
41.
41. Silye R, Syrigos KN, Karayiannakis AJ, Poole S, van Noorden S, Batchelor W, Regele H, Sega W, Boesmuller H, Krausz T, Pignatelli M.Ecadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol186:340-342, 1998
42.
42. Ohene-Abuakwa Y, Noda M, Kobayashi N, Kashima K, Hattori T, Pignatelli M.Expression of E-cadherin/catenin complex correlates with macroscopic appearance of early gastric cancer. J Pathol (in press)
43.
43. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. E-cadherin expression in squamous cell carcinomas of the head and neck: Inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res51:6328-6337, 1991
44.
44. Ansari T, Lemoine N, Gunter P, Liu D, Hirano S, Takeichi M, Kloppel G, Pignatelli M.Decreased Ecadherin expression correlates with lymph node metastasis, high-grade and advanced stage in pancreatic cancer. J Pathol172:A12-A12, 1994
45.
45. Bringuier PP, Umbas R, Schaafsma HW, Karthaus HFM, Debruyne FMJ, Schaken JA. Decreased Ecadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res53:3241-3245, 1993
46.
46. Vessey CJ, Wilding J, Folarin N, Hirano S, Takeichi M, Soutter P, Stamp GWH, Pignatelli M.Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J Pathol176:151-159, 1995
47.
47. Davies BR, Worsley SD, Ponder BA. Expression of Ecadherin, acatenin and 1-catenin in normal ovarian surface epithelial and epithelial ovarian cancer. Histopathology32:69-80, 1998
48.
48. Hiraguri S, Godfrey T, Nakamura H, Graff J, Collins C, Shayesteh L, Doggett N, Johnson K, Wheelock M, Herman J, Baylin S, Pinkel D, Gray J.Mechanism of inactivation of E-cadherin in breast cancer cell lines. Cancer Res58:1972-1977, 1998
49.
49. Gumbiner BM, McCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci17(Suppl):155-158, 1993
50.
50. Reynolds ABJ, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z.Identification of new catenin: The tyrosine kinase substrate pl20cas associates with E-cadherin complexes. Mol Cell Biol14:8383-8342, 1994
51.
51. Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K, Nagafuchi A, Tsukita S, Shibamoto S, Ito F, Takeichi M, Matsuda H, Hirohashi S.A truncated,B-catenin disrupts the interaction between E-cadherin and ox-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res54:6282-6287, 1994
52.
52. Valizadeh A.Karayiannakis AJ, El-Hariry I, Kimot W, Pignatelli M.Expression of E-cadherin-associated molecules (oc-, Iand 7-catenins and p120) in colorectal polyps. Am J Pathol150:1977-1984, 1997
53.
53. Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, Inoue M, Monden T, Ito F, Monden M.Beta-catenin expression in human cancers. Am J Pathol48:39-46, 1996
54.
54. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJG. Abnormal immunoreactivity of E-cadherin-catenin complex in gastric carcinoma: Relationship with patients survival. Gastroenterology112:46-54, 1997
56. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W.Functional mutation of beta-catenin with transcriptional factor LEF-1. Nature382:638-642, 1996
57.
57. De LaCoste A, Romagnolo B, Billuart P, Renard C-A, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Khan A, Perret C.Somatic mutation of the J-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA95:8847-8851, 1998
58.
58. Staddon JM, Smales C, Schulze C, Esch FS, Rubin LL. P120, a p120-related protein (plO0) and the cadherin/catenin complexes. J Cell Biol130:369-381, 1995
59.
59. Volberg T, Zick Y, Dror R, Sabanay I, Gilon C, Levitzki A, Geiger B.The effect of tyrosine-specific protein phosphorylation on the assembly of adherenstype junction. EMBO J11:1733-1742, 1992
60.
60. Beckner ME, Krutzsch HC, Stracke ML, Williams ST, Gallardo JA, Liotta LA. Identification of a new immunoglobulin superfamily protein expression in blood vessels with a heparin-binding consensus sequence. Cancer Res55:2140-2149, 1995
61.
61. Landuzzi L, Frabetti F, Rossi I, Griffoni C, De Giovanni C, Nicoletti G, Nanni P, Miniero R, Palmieri G, Santoni A, Lollini P-L. Expression of transduced carcinoembryonic antigen gene in human rhabdomyosarcoma inhibits metastasis. Cancer Res56:4503-4508, 1996
62.
62. Pignatelli M, Durbin H, Bodmer WF. Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interactions. Proc Natl Acad Sci USA87:1541-1545, 1990
63.
63. Jothy S, Yuan S-Y, Shirota K.Transcription of carcinoembryonic antigen in normal colon and colon carcinoma: In situ hybridization study and the implication for a new in vivo functional model. Am J Pathol143:250-257, 1993
64.
64. Roit I, Brostoff J, Male D. Immunology, 4th ed.Mosby, London, 1996
65.
65. Maio M, Pinto A, Carbone A, Zagonel V, Gloghini A, Marotta G, Cirillo D, Colombatti A, Ferrara F, Delvecchio L.Differential expression of CD45/intercellular adhesion molecule 1 in myeloid leukemias and lymphoproliferative disorders. Blood76:783-790, 1990
66.
66. Passlick B, Izbicki JR, Simmel S, Kubuschok B, Karg O, Habekost M, Thetter O, Schweiberrer L, Pantel K. Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecules 1 on operable non small cell lung carcinomas: Frequency and prognostic significance. Eur J Cancer30A:376-381, 1994
67.
67. Wolff JM, Stephenson RN, Chisholm GD, Habib FK. Levels of circulating intercellular adhesion molecule 1 in patients with metastatic cancer of the prostate and benign prostate hyperplasia. Eur J Cancer31A:339-341, 1995
68.
68. Vora AR, Rodgers S, Parker AJ, Start R, Rees RC, Murray AK. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma. Br J Cancer76:836-844, 1997
69.
69. Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G.De novo expression of intercellularadhesion molecule in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA86:641-644, 1989
70.
70. Natali P, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferone S.Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res50:1271-1278, 1990
71.
71. Natali PG, Hamby CV, Felding-Habermann B, Liang B, Nicotra MR, DiFilippo F, Giannarelli D, Temponi M, Ferone S.Clinical significance of alpha(v)beta3 intergrin and intercellular adhesion molecule 1 expression in cutaneous malignant melanoma lesions. Cancer Res57:1554-1560, 1997
72.
72. Hatzistilianou M, Athanassiadou F, Agguridaki C, Catriu D.Circulating soluble adhesion molecules levels in children with acute lymphoblastic leukemia. Eur J Paediatr156:537-540, 1997
73.
73. Schadendorf D, Diehl S, Zuberbier T, Schadendorf C, Henz BM. Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage. Dermatology192:89-93, 1996
74.
74. Christiansen I, Gidlof C, Kalkner KM, Hagberg H, Bennmarker H, Totermann T.Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphoma correlates with tumor burden, clinical activity, and other prognostic markers. Br J Haematology92:639-646, 1996
75.
75. Shimizu Y, Minemura M, Tsukishiro T, Kashii Y, Miyamoto M, Nishimori H, Higuchi K, Watanabe A.Serum concentration of intercellular adhesion molecules 1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology22:525-531, 1995
76.
76. Christiansen I, Sundstrom C, Enblad G, Totermann TH. Soluble vascular cell adhesion molecule-I (sVCAM) is an independent prognostic marker in Hodgkins's disease. Br J Haematology102:701-709, 1998
77.
77. Fearon ER, Cho KR, Nigro JM, Kern SE, Simmons JW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Volgestein B.Identification of chromosome 18q gene that is altered in colorectal cancers. Science247:49-56, 1990
78.
78. Wu SQ, Storer BE, Bookland EA, et al. Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells. Cancer Res51:3323-3326, 1991
79.
79. Hohne MW, Halatsch ME, Kahl GF, Weinel RJ. Frequent loss of expression of potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res52:2616-2619, 1992
81. Matsushita Y, Cleary KR, Ota DA, Hoff SD, Irimura T.Sialyldomeric Lewis-X antigen expressed on mucin-like glycoprotein in colorectal cancer metastases. Lab Invest63:780-791, 1990
82.
82. Lauri D, Needham L, Martin-Padura I, Dejana E.Tumor cell adhesion to endothelial cells: Endothelial leukocyte adhesion moleculeI as an inducible adhesive receptor specific for colon carcinoma cells. J Natl Cancer Inst83:1321-1324, 1991
83.
83. Benekli M, Gullu IH, Tekuzman G, Savas MC, Hayran M, Hascelik G, Firat D.Circulating intercellular adhesion moleculesI and E-selectin levels in gastric cancer. Br J Cancer78:267-271, 1998
84.
84. Imai Y, Lasky LA, Rosen SD. Further characterization of the interaction between L-selectin and its endothelial ligands. Glycobiology2:373-381, 1992
85.
85. Gunthert U.CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immunol184:47-63,, 1993
86.
86. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B.CD44 is the principal cell surface receptor for hyaluronate. Cell61:1303-1313, 1990
87.
87. Matsamura Y, Tarin D.Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet340:1053-1058, 1992
88.
88. Stamenkovic I, Amiot M, Pesando JM, Seed B.A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell56:1057-1062, 1989
89.
89. Stamenkovic I, Aruffo A, Amiot M, Seed B.The hematopoietic and epithelial forms of CD44 are distinct polypeptydes with different adhesion potentials for hyaluronate bearing cells. EMBO J10:343-348, 1991
90.
90. Woodman AW, Sugiyama K, Yoshida K, et al. Analysis of deranged CD44 gene expression in breast, bladder, and colon cancer by correlated studies on mRNA and protein isoform. Am J Pathol149:1519-1530, 1996
91.
91. Kawahara K, Yoshino T, Kawasaki N, Miyake K, Akagi T.Abnormal expression of human CD44 gene in early colorectal malignancy with specific reference to variant exon 9 (9v). J Clin Pathol49:478-481, 1996
92.
92. Goodison S, Tarin D.Current status of CD44 variant isoforms as cancer diagnostic markers. Histopathology32:1-6, 1998
93.
93. Wielenga VJM, Heider K-H, Offerhaus GJA, Adolf GR, van der Berg FM, Ponta H, Herrlick P, Pals ST. Expression of CD44 variant protein in human colorectal cancer is related to tumor progression. Cancer Res53:4754-4756, 1993
95. Joensuu H, Klemi PJ, Toikkanen S, Jalkenan S. Glycoprotein CD44 expression and its association with survival in breast cancer. Am J Pathol143:867-874, 1993
96.
96. Cannistra SA, Kansas GS, Niloff J, DeFranzo B, Kim Y, Ottensmeier C.Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res53:3830-3838, 1993
97.
97. Hofmann M, Rudy W, Zoller M, Tolf C, Ponta H, Herrlich P, Gunthert U.CD44 splice variant confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res51:5292-5297, 1991
98.
98. Li H, Hamou M, Tibolet N, Jaufeerally R, Hofmann M, Diserens A, Van Meir EG. Variant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastomas. Cancer Res53:5345-5349, 1993
99.
99. Birch M, Mitchell S, Hart IR. Isolation and characterization of human melanoma cell variants expression high and low levels of CD44. Cancer Res51:6660-6667, 1991
100.
100. Heider KH, Hofmann M, Hors E, van den Berg F, Ponta H, Herrlich P, Pals ST. A human homologue of the rat metastasis-associated variant in CD44 is expressed in colorectal carcinomas and adenomatous polyps. J Cell Biol120:227-233, 1993
